1 Min Read
May 2 (Reuters) - PLEDPHARMA AB (PUBL)
* PLEDPHARMA RECEIVES ADVICE FROM THE FDA FOR THE CONTINUED DEVELOPMENT OF PLEDOX® Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.